We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04204928
Brief Title: Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

First Submitted : December 17, 2019
First Submitted that Met QC Criteria : December 17, 2019
First Posted : December 19, 2019

Last Update Submitted that Met QC Criteria : August 9, 2021
Last Update Posted : August 13, 2021